Literature DB >> 8567349

Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer.

Y Nakayama1, S Makino, Y Fukuda, K Y Min, A Shimizu, N Ohsawa.   

Abstract

PURPOSE: Radiation pneumonitis sometimes extends beyond the irradiated area of a lung and can also affect the opposite lung. Some immunological mechanisms, in addition to simple direct injury of the lungs by radiation, seem to be involved in the onset of radiation pneumonitis. To clarify such mechanisms, the effects of radiation on local inflammatory cells in lungs, in particular, lymphocytes, were examined. METHODS AND MATERIALS: A comparison was made of bronchoalveolar lavage fluid (BALF) findings from 13 irradiated patients (RT group) and 15 nonirradiated patients (non-RT group) with lung cancer. Patients who later developed radiation pneumonitis (RP group) and those who did not (RP-free group) were also compared. Using a two-color flowcytometer, radiation-induced changes in local inflammatory cells in lungs were analyzed. This included analyses of human leukocyte-associated antigen (HLADR) and intercellular adhesion molecule-1 (ICAM-1) expression on T-cells, which are though to be involved in cell activation and interactions between cells.
RESULTS: The following aspects of BALF were higher in the RT group than in the non-RT group: (a) the percentage of lymphocytes and eosinophiles; (b) the incidence of HLADR-positive CD4+T-cells and HLADR-positive CD8+T-cells; and (c) the incidence of ICAM-1--positive T-cells. The following aspects of BALF were higher in the RP group than in the RP-free group: (a) the total cell counts; (b) the percentage of lymphocytes; and (c) the incidence of ICAM-1-positive T-cells. A significant relationship was seen between the incidence of ICAM-1 expression on T-cells and the number of days from the initiation of radiotherapy to the onset of radiation pneumonitis.
CONCLUSION: These data suggest that irradiation can induce accumulation of activated T-cells (HLADR and ICAM-1--positive T-cells) in the lung. This accumulation may be closely linked to radiation-induced lung injury. It is also suggested that the incidence of ICAM-1--positive T-cells in BALF may serve as a useful clinical marker of radiation pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8567349     DOI: 10.1016/0360-3016(95)02101-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

Review 1.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

2.  MyD88 provides a protective role in long-term radiation-induced lung injury.

Authors:  Willie J Brickey; Isabel P Neuringer; William Walton; Xiaoyang Hua; Ellis Y Wang; Sushmita Jha; Gregory D Sempowski; Xuebin Yang; Suzanne L Kirby; Stephen L Tilley; Jenny P-Y Ting
Journal:  Int J Radiat Biol       Date:  2012-02-06       Impact factor: 2.694

Review 3.  Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma.

Authors:  Anusha Kalbasi; Ramesh Rengan
Journal:  Transl Lung Cancer Res       Date:  2017-04

4.  Radiation pneumonitis in lung cancer treated with volumetric modulated arc therapy.

Authors:  Kan Wu; Xiao Xu; Xiadong Li; Jiahao Wang; Lucheng Zhu; Xueqin Chen; Bing Wang; Minna Zhang; Bing Xia; Shenglin Ma
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

5.  Cryptogenic organizing pneumonia after radiotherapy for breast cancer.

Authors:  Giorgio Fumagalli; Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2010-12-20

6.  T lymphocytes and normal tissue responses to radiation.

Authors:  Dörthe Schaue; William H McBride
Journal:  Front Oncol       Date:  2012-09-19       Impact factor: 6.244

7.  Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells.

Authors:  Florian Wirsdörfer; Federica Cappuccini; Muska Niazman; Simone de Leve; Astrid M Westendorf; Lutz Lüdemann; Martin Stuschke; Verena Jendrossek
Journal:  Radiat Oncol       Date:  2014-04-25       Impact factor: 3.481

Review 8.  The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung.

Authors:  Florian Wirsdörfer; Verena Jendrossek
Journal:  Front Immunol       Date:  2016-12-14       Impact factor: 7.561

Review 9.  A Century of Radiation Therapy and Adaptive Immunity.

Authors:  Dörthe Schaue
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

10.  Dynamic changes in T-cell subsets and C-reactive protein after radiation therapy in lung cancer patients and correlation with symptomatic radiation pneumonitis treated with steroid therapy.

Authors:  Lu Bai; Bao-Sen Zhou; Yu-Xia Zhao
Journal:  Cancer Manag Res       Date:  2019-08-22       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.